John R. Jacobsen

Person

San Mateo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 11,548,887
- Issue date Jan 10, 2023
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-17 ligands and uses thereof
- Patent number 11,447,468
- Issue date Sep 20, 2022
- DICE ALPHA, INC.
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,299,492
- Issue date Apr 12, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted benzenecarboxamides as IL-17A modulators
- Patent number 11,274,094
- Issue date Mar 15, 2022
- DICE ALPHA, INC.
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,913,740
- Issue date Feb 9, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,836,744
- Issue date Nov 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 10,745,394
- Issue date Aug 18, 2020
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and Beta2 a...
- Patent number 10,590,107
- Issue date Mar 17, 2020
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,526,330
- Issue date Jan 7, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 10,377,751
- Issue date Aug 13, 2019
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 10,358,433
- Issue date Jul 23, 2019
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonis and beta2 ad...
- Patent number 10,138,220
- Issue date Nov 27, 2018
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,100,049
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 10,081,626
- Issue date Sep 25, 2018
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and Beta2 a...
- Patent number 9,975,875
- Issue date May 22, 2018
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,771,350
- Issue date Sep 26, 2017
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adr...
- Patent number 9,682,957
- Issue date Jun 20, 2017
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 9,663,509
- Issue date May 30, 2017
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,572,802
- Issue date Feb 21, 2017
- Theravance Respiratory Company LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and BETA2 a...
- Patent number 9,394,275
- Issue date Jul 19, 2016
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 9,206,172
- Issue date Dec 8, 2015
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 9,000,173
- Issue date Apr 7, 2015
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 8,927,573
- Issue date Jan 6, 2015
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 8,816,088
- Issue date Aug 26, 2014
- Theravance Respiratory Company, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-carboxypropyl-aminotetralin derivatives and related compounds as...
- Patent number 8,703,791
- Issue date Apr 22, 2014
- Theravance, Inc.
- Sean G. Trapp
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
- Patent number 8,664,242
- Issue date Mar 4, 2014
- Theravance, Inc.
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diamide compounds having muscarinic receptor antagonist and β2 adre...
- Patent number 8,551,978
- Issue date Oct 8, 2013
- Theravance, Inc.
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid recepto...
- Patent number 8,518,966
- Issue date Aug 27, 2013
- Theravance, Inc.
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminotetralin compounds as mu opioid receptor antagonists
- Patent number 8,497,287
- Issue date Jul 30, 2013
- Theravance, Inc.
- Michael R. Leadbetter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF
- Publication number 20240208968
- Publication date Jun 27, 2024
- DiCE Molecules SV, Inc.
- Lalit Kumar SHARMA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20230183232
- Publication date Jun 15, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
- Publication number 20230145481
- Publication date May 11, 2023
- DiCE Alpha, Inc.
- Paul R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
- Publication number 20230141212
- Publication date May 11, 2023
- DiCE Alpha, Inc.
- Paul R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-17 LIGANDS AND USES THEREOF
- Publication number 20230053746
- Publication date Feb 23, 2023
- DiCE Alpha, Inc.
- Paul R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
- Publication number 20220235038
- Publication date Jul 28, 2022
- DiCE Alpha, Inc.
- Paul R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20210130351
- Publication date May 6, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-17A MODULATORS AND USES THEREOF
- Publication number 20210101886
- Publication date Apr 8, 2021
- DiCE Alpha, Inc.
- Paul R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20210024493
- Publication date Jan 28, 2021
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20210024515
- Publication date Jan 28, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-17 Ligands And Uses Thereof
- Publication number 20200247785
- Publication date Aug 6, 2020
- DICE Molecules SV LLC.
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20200165223
- Publication date May 28, 2020
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20200087303
- Publication date Mar 19, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20190308966
- Publication date Oct 10, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190300504
- Publication date Oct 3, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20190119267
- Publication date Apr 25, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20190106420
- Publication date Apr 11, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20190047984
- Publication date Feb 14, 2019
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170362200
- Publication date Dec 21, 2017
- Theravance Respiratory Compa, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20170349578
- Publication date Dec 7, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170226082
- Publication date Aug 10, 2017
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20170096412
- Publication date Apr 6, 2017
- Theravance Respiratory Company, LLC
- Adam D. HUGHES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...
- Publication number 20160361304
- Publication date Dec 15, 2016
- THERAVANCE RESPIRATORY COMPANY, LLC
- Adam D. HUGHES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20160176863
- Publication date Jun 23, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20150291579
- Publication date Oct 15, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...
- Publication number 20150274697
- Publication date Oct 1, 2015
- THERAVANCE RESPIRATORY COMPANY, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...
- Publication number 20140323733
- Publication date Oct 30, 2014
- THERAVANCE RESPIRATORY COMPANY, LLC
- Adam D. Hughes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS
- Publication number 20140288112
- Publication date Sep 25, 2014
- Theravance, Inc.
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John R. Jacobsen

Person

Patents Grantslast 30 patents

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

IL-17 ligands and uses thereof

JAK kinase inhibitor compounds for treatment of respiratory disease

Substituted benzenecarboxamides as IL-17A modulators

JAK kinase inhibitor compounds for treatment of respiratory disease

Diamide compounds having muscarinic receptor antagonist and β2 adre...

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and Beta2 a...

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Diamide compounds having muscarinic receptor antagonis and beta2 ad...

JAK kinase inhibitor compounds for treatment of respiratory disease

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and Beta2 a...

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Diamide compounds having muscarinic receptor antagonist and β2 adr...

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Diamide compounds having muscarinic receptor antagonist and BETA2 a...

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adre...

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adre...

3-carboxypropyl-aminotetralin derivatives and related compounds as...

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Diamide compounds having muscarinic receptor antagonist and β2 adre...

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid recepto...

Aminotetralin compounds as mu opioid receptor antagonists

Patents Applicationslast 30 patents

ALPHA V BETA 6 AND ALPHA V BETA 1 INTEGRIN INHIBITORS AND USES THEREOF

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

IL-17 LIGANDS AND USES THEREOF

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

IL-17A MODULATORS AND USES THEREOF

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

IL-17 Ligands And Uses Thereof

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 A...

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS

DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...

DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 A...

8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS